Cancer Immunotherapy

Cancer diagnostic kits are essential tools for early detection and accurate diagnosis, empowering healthcare providers to identify cancers like breast cancer, lung cancer, and prostate cancer with precision. As a leading supplier of advanced oncology solutions, our pharmaceutical export platform offers high-quality cancer diagnostic kits designed for reliability and efficiency in clinical settings. These cutting-edge kits enable rapid and accurate testing, supporting timely treatment decisions for improved patient outcomes.

Bevacizumab 100mg Injection (VEGF Inhibitor)
Rituximab
Trastuzumab (Ab-Her-2)
Serplulimab
Nivolumab (PD-1 Inhibitor)
Pembrolizumab (PD-1 Inhibitor)
Toripalimab
Denosumab
Atezolizumab (PD-L1 Inhibitor)
Durvalumab
Ipilimumab (CTLA-4 Inhibitor)
Cosibelimab (PD-L1 Inhibitor)
Cetuximab (EGFR inhibitor)